Our Board of Directors

Elisa Kahn, Non-executive Director

Elisa’s career spans more than 25 years in investment banking working for Mizhuho Bank, Lehman Brothers and Merrill Lynch where she specialized in debt capital markets. She is the founder of W Global Capital, set-up in 2016, which focuses heavily on the biotech/biopharma markets globally introducing companies at various stages of development to potential funding partners. Prior to W Global Capital, Elisa worked for Knight Capital helping Asian based investors restructure their portfolios after the crash in 2008, the Greek government bond crisis and other difficult and delicate situations. Elisa worked for more than 10 years at Lehman Brothers where she set up a fixed income Japan/Asian sales group. She is a fluent Japanese and Mandarin (Chinese) speaker.

Dr. Naz Bashir, Non-executive Director

Naz has over twenty years of experience as an entrepreneur in early-stage companies, in/out licensing, investment strategies and in commercial and business development. He has achieved success in driving sales from licensing, strategic partnerships in the biotech, chemicals, biofuels and food sectors; deal packages up to $100 million. Dr. Bashir has held executive roles and raised finance as part of the management team with a nutraceutical company, an oil and gas company, a biopharmaceutical company, and a biosensor company. Naz managed a university seed fund achieving out licensing of biological technologies, chemical assets and value through exits and an IPO. More recently, he co-founded an Omega 3 company in which he invested in and successfully raised an EIS round which is leading to strategic investments/partnerships. He also acts as advisor, consultant and is a non-executive director on numerous early-stage biotech in digital wound care (antimicrobial), gut health (microbiome) and a digital therapeutics incubator. He has a PhD in Chemistry and an MBA from the University of Exeter.

Paul van den Biggelaar, CEO of Sensius

Paul has studied the potential of thermotherapy for over a decade. He has more than 30 years of experience in High Tech, of which he spent 15 years as an Executive. Before co-founding and leading Sensius in 2015, Paul had co-founded and led NRGLed and HEARConcepts. He is also an Entrepreneur at ThinkThrough, a company that invests in high tech ideas and concepts to turn them into products and companies. Prior to that Paul was an Executive at Nucletron where he was Business Unit Director and later responsible for all product development. Paul has a MSc degree in Electrical Engineering from Eindhoven University of Technology.

Comments are closed.